{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T20:51:15Z","timestamp":1791492675324,"version":"4.3.4"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Archives of Gerontology and Geriatrics"],"published-print":{"date-parts":[[2027,1]]},"DOI":"10.1016\/j.archger.2026.106443","type":"journal-article","created":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T15:39:18Z","timestamp":1790869158000},"page":"106443","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Insights from the therapy of heart failure at discharge (TESCODI) study: how far from full appropriateness are we in older and frail patients?"],"prefix":"10.1016","volume":"152","author":[{"given":"Francesco","family":"Cei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonella Al","family":"Refaie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Dolenti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giacomo","family":"Campi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franco","family":"Cipollini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Borromei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federico","family":"Parolini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grazia","family":"Panigada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Bulli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona","family":"Filetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filippo","family":"Vannoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"D\u2019Errico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Pelagalli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone","family":"Venturini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrico","family":"Benvenuti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Tarquini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.archger.2026.106443_bib0001","article-title":"Hospitalization in adults \u2013 Heart failure","year":"2026","journal-title":"ARS Toscana"},{"issue":"1","key":"10.1016\/j.archger.2026.106443_bib0036","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1159\/000528505","article-title":"The optimization of guideline-directed medical therapy during hospitalization among patients with heart failure with reduced ejection fraction in daily clinical practice","volume":"148","author":"B\u00e1nfi-Bacs\u00e1rdi","year":"2023","journal-title":"Cardiology"},{"issue":"2","key":"10.1016\/j.archger.2026.106443_bib0032","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1093\/ageing\/afaa159","article-title":"Deprescribing in older people approaching end-of-life: Development and validation of STOPPFrail version 2","volume":"50","author":"Curtin","year":"2021","journal-title":"Age and Ageing"},{"key":"10.1016\/j.archger.2026.106443_bib0018","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijcard.2025.133386","article-title":"Loop diuretics, heart failure diagnosis and outcome in primary care","volume":"435","author":"Cuthbert","year":"2025","journal-title":"International Journal of Cardiology"},{"issue":"22","key":"10.1016\/j.archger.2026.106443_bib0040","doi-asserted-by":"crossref","first-page":"2836","DOI":"10.1016\/j.jacc.2020.04.021","article-title":"Abnormalities of potassium in heart failure: JACC state-of-the-art review","volume":"75","author":"Ferreira","year":"2020","journal-title":"Journal of the American College of Cardiology"},{"issue":"11","key":"10.1016\/j.archger.2026.106443_bib0006","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1161\/CIRCULATIONAHA.118.037778","article-title":"Empagliflozin reduced mortality and hospitalization for heart failure across the spectrum of cardiovascular risk in the EMPA-REG OUTCOME trial","volume":"139","author":"Fitchett","year":"2019","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.archger.2026.106443_bib0025","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.jacc.2008.03.048","article-title":"OPTIMIZE-HF Investigators and Coordinators. Influence of beta-blocker continuation or withdrawal on outcomes in patients hospitalized with heart failure: Findings from the OPTIMIZE-HF program","volume":"52","author":"Fonarow","year":"2008","journal-title":"Journal of the American College of Cardiology"},{"issue":"6","key":"10.1016\/j.archger.2026.106443_bib0024","first-page":"e287","article-title":"Triple therapy at discharge from internal medicine wards in heart failure patients with reduced ejection fraction: Results from an observational study","volume":"169","author":"Fortini","year":"2018","journal-title":"La Clinica Terapeutica"},{"issue":"9","key":"10.1016\/j.archger.2026.106443_bib0042","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1080\/13543784.2023.2263354","article-title":"SGLT2 inhibitors: An evidence-based update on cardiovascular implications","volume":"32","author":"Forzano","year":"2023","journal-title":"Expert Opinion on Investigational Drugs"},{"issue":"37","key":"10.1016\/j.archger.2026.106443_bib0017","doi-asserted-by":"crossref","first-page":"3837","DOI":"10.1093\/eurheartj\/ehae345","article-title":"Loop diuretic therapy with or without heart failure: Impact on prognosis","volume":"45","author":"Friday","year":"2024","journal-title":"European Heart Journal"},{"issue":"2","key":"10.1016\/j.archger.2026.106443_bib0026","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.116.004675","article-title":"Initiation, continuation, or withdrawal of angiotensin-converting enzyme inhibitors\/angiotensin receptor blockers and outcomes in patients hospitalized with heart failure with reduced ejection fraction","volume":"6","author":"Gilstrap","year":"2017","journal-title":"Journal of the American Heart Association"},{"issue":"1","key":"10.1016\/j.archger.2026.106443_bib0016","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1186\/s12872-024-03961-5","article-title":"Prescribing trends of SGLT2 inhibitors among HFrEF and HFpEF patients with and without T2DM, 2013-2021","volume":"24","author":"Gonzalez","year":"2024","journal-title":"BMC Cardiovascular Disorders"},{"issue":"4","key":"10.1016\/j.archger.2026.106443_bib0013","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.jacc.2018.04.070","article-title":"Medical therapy for heart failure with reduced ejection fraction: The CHAMP-HF registry","volume":"72","author":"Greene","year":"2018","journal-title":"Journal of the American College of Cardiology"},{"issue":"11","key":"10.1016\/j.archger.2026.106443_bib0019","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1002\/ejhf.2605","article-title":"BLITZ-HF Investigators. BLITZ-HF: A nationwide initiative to evaluate and improve adherence to acute and chronic heart failure guidelines","volume":"24","author":"Gulizia","year":"2022","journal-title":"European Journal of Heart Failure"},{"issue":"18","key":"10.1016\/j.archger.2026.106443_bib0005","first-page":"E895","article-title":"2022 AHA\/ACC\/HFSA guideline for the management of heart failure: A report of the American college of cardiology\/American heart association joint committee on clinical practice guidelines","volume":"145","author":"Heidenreich","year":"2022","journal-title":"Circulation"},{"issue":"10458","key":"10.1016\/j.archger.2026.106443_bib0039","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/S0140-6736(24)01733-1","article-title":"Mineralocorticoid receptor antagonists in heart failure: An individual patient level meta-analysis","volume":"404","author":"Jhund","year":"2024","journal-title":"Lancet (London, England)"},{"issue":"658","key":"10.1016\/j.archger.2026.106443_bib0031","doi-asserted-by":"crossref","first-page":"235","DOI":"10.3399\/bjgp17X690857","article-title":"Clinical assessment and management of multimorbidity: NICE guideline","volume":"67","author":"Kernick","year":"2017","journal-title":"The British Journal of General Practice : The Journal of the Royal College of General Practitioners"},{"issue":"4S","key":"10.1016\/j.archger.2026.106443_bib0033","first-page":"S117","article-title":"Improving Global outcomes (KDIGO) CKD Work Group. KDIGO 2024 clinical practice guideline for the evaluation and management of chronic kidney disease","volume":"105","year":"2024","journal-title":"Kidney International"},{"issue":"1","key":"10.1016\/j.archger.2026.106443_bib0021","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1002\/ehf2.15049","article-title":"Real-world data on Empagliflozin and Dapagliflozin use in patients with HEART failure: The RED-HEART study","volume":"12","author":"Kocabas","year":"2025","journal-title":"ESC Heart Failure"},{"issue":"8","key":"10.1016\/j.archger.2026.106443_bib0037","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1016\/j.jchf.2024.04.027","article-title":"Low natriuretic peptide levels and outcomes in patients with heart failure and preserved ejection fraction","volume":"12","author":"Kondo","year":"2024","journal-title":"JACC. Heart Failure"},{"issue":"20","key":"10.1016\/j.archger.2026.106443_bib0014","first-page":"976","article-title":"Mineralocorticoid receptor antagonist (MRA) use in UK heart failure care: A national primary care cohort study","volume":"111","author":"Maclean","year":"2025","journal-title":"Heart (British Cardiac Society)"},{"issue":"5\u20136","key":"10.1016\/j.archger.2026.106443_bib0027","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1159\/000519014","article-title":"Patterns of use and clinical outcomes with angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in acute heart failure and changes in kidney function: An analysis of the veterans' Health administrative database","volume":"11","author":"Mathew","year":"2021","journal-title":"Cardiorenal Medicine"},{"issue":"36","key":"10.1016\/j.archger.2026.106443_bib0004","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","article-title":"2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"42","author":"McDonagh","year":"2021","journal-title":"European Heart Journal"},{"issue":"37","key":"10.1016\/j.archger.2026.106443_bib0011","doi-asserted-by":"crossref","first-page":"3627","DOI":"10.1093\/eurheartj\/ehad195","article-title":"2023 Focused update of the 2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"44","author":"McDonagh","year":"2023","journal-title":"European Heart Journal"},{"issue":"21","key":"10.1016\/j.archger.2026.106443_bib0007","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1056\/NEJMoa1911303","article-title":"DAPA-HF trial committees and investigators. Dapagliflozin in patients with heart failure and reduced ejection fraction","volume":"381","author":"McMurray","year":"2019","journal-title":"The New England Journal of Medicine"},{"issue":"10367","key":"10.1016\/j.archger.2026.106443_bib0022","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1016\/S0140-6736(22)02076-1","article-title":"Safety, tolerability and efficacy of up-titration of guideline-directed medical therapies for acute heart failure (STRONG-HF): A multinational, open-label, randomised, trial","volume":"400","author":"Mebazaa","year":"2022","journal-title":"Lancet (London, England)"},{"issue":"14","key":"10.1016\/j.archger.2026.106443_bib0010","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1093\/eurheartj\/ehr254","article-title":"The survival of patients with heart failure with preserved or reduced left ventricular ejection fraction: An individual patient data meta-analysis","volume":"33","year":"2012","journal-title":"European Heart Journal"},{"issue":"7","key":"10.1016\/j.archger.2026.106443_bib0043","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1093\/cvr\/cvag065","article-title":"Sodium\/glucose cotransporters 2 inhibitors but not other antidiabetic drugs improve frailty in older adults with diabetes and heart failure with preserved ejection fraction","volume":"122","author":"Mone","year":"2026","journal-title":"Cardiovascular Research"},{"issue":"5","key":"10.1016\/j.archger.2026.106443_bib0044","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.2337\/dc21-2434","article-title":"Empagliflozin improves cognitive impairment in frail older adults with type 2 diabetes and heart failure with preserved ejection fraction","volume":"45","author":"Mone","year":"2022","journal-title":"Diabetes Care"},{"issue":"3","key":"10.1016\/j.archger.2026.106443_bib0034","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.ihj.2016.08.007","article-title":"Angiotensin-converting enzyme inhibitors and receptor blockers in heart failure and chronic kidney disease - demystifying controversies","volume":"69","author":"Muneer","year":"2017","journal-title":"Indian Heart Journal"},{"issue":"3","key":"10.1016\/j.archger.2026.106443_bib0029","doi-asserted-by":"crossref","first-page":"876","DOI":"10.3390\/biomedicines11030876","article-title":"Predictors and outcomes of SGLT2 inhibitor discontinuation in a real-world population after hospitalization for heart failure","volume":"11","author":"Nakagaito","year":"2023","journal-title":"Biomedicines"},{"issue":"15","key":"10.1016\/j.archger.2026.106443_bib0008","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1056\/NEJMoa2022190","article-title":"EMPEROR-reduced trial investigators. Cardiovascular and renal outcomes with empagliflozin in heart failure","volume":"383","author":"Packer","year":"2020","journal-title":"The New England Journal of Medicine"},{"issue":"6","key":"10.1016\/j.archger.2026.106443_bib0028","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1161\/CIRCHEARTFAILURE.113.000872","article-title":"Hypotension during hospitalization for acute heart failure is independently associated with 30-day mortality: Findings from ASCEND-HF","volume":"7","author":"Patel","year":"2014","journal-title":"Circulation. Heart failure"},{"issue":"2","key":"10.1016\/j.archger.2026.106443_bib0012","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1001\/jama.289.2.194","article-title":"Burden of systolic and diastolic ventricular dysfunction in the community: Appreciating the scope of the heart failure epidemic","volume":"289","author":"Redfield","year":"2003","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.archger.2026.106443_bib0002","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1001\/jama.292.3.344","article-title":"Trends in heart failure incidence and survival in a community-based population","volume":"292","author":"Roger","year":"2004","journal-title":"JAMA"},{"issue":"5","key":"10.1016\/j.archger.2026.106443_bib0035","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1007\/s13300-024-01550-5","article-title":"SGLT2 Inhibitors - the new standard of care for cardiovascular, renal and metabolic protection in type 2 diabetes: A narrative review","volume":"15","author":"Seidu","year":"2024","journal-title":"Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders"},{"issue":"8","key":"10.1016\/j.archger.2026.106443_bib0015","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.jacc.2024.05.057","article-title":"Prescription patterns for sodium-glucose cotransporter 2 inhibitors in U.S. Health systems","volume":"84","author":"Shin","year":"2024","journal-title":"Journal of the American College of Cardiology"},{"issue":"16","key":"10.1016\/j.archger.2026.106443_bib0041","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1056\/NEJMoa2407107","article-title":"FINEARTS-HF Committees and Investigators. Finerenone in heart failure with mildly reduced or preserved ejection fraction","volume":"391","author":"Solomon","year":"2024","journal-title":"The New England Journal of Medicine"},{"issue":"1","key":"10.1016\/j.archger.2026.106443_bib0038","doi-asserted-by":"crossref","first-page":"27","DOI":"10.5334\/gh.1418","article-title":"Characterization of 2500 patients with heart failure and analysis of their optimal medical therapy: Insights from the AMERICCAASS registry","volume":"20","author":"Sotomayor-Julio","year":"2025","journal-title":"Global Heart"},{"issue":"9","key":"10.1016\/j.archger.2026.106443_bib0020","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1002\/ejhf.2971","article-title":"Real-world use of sodium-glucose cotransporter 2 inhibitors in patients with heart failure and reduced ejection fraction: Data from the Swedish Heart failure registry","volume":"25","author":"Stolfo","year":"2023","journal-title":"European Journal of Heart Failure"},{"issue":"2","key":"10.1016\/j.archger.2026.106443_bib0009","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.jchf.2021.09.004","article-title":"A systematic review and network meta-analysis of pharmacological treatment of heart failure with reduced ejection fraction","volume":"10","author":"Tromp","year":"2022","journal-title":"JACC. Heart Failure"},{"issue":"6","key":"10.1016\/j.archger.2026.106443_bib0003","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1056\/NEJMoa1812851","article-title":"Angiotensin-neprilysin inhibition in acute decompensated heart failure","volume":"380","author":"Velazquez","year":"2019","journal-title":"The New England Journal of Medicine"},{"issue":"3","key":"10.1016\/j.archger.2026.106443_bib0023","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1038\/s41591-021-01659-1","article-title":"The SGLT2 inhibitor empagliflozin in patients hospitalized for acute heart failure: A multinational randomized trial","volume":"28","author":"Voors","year":"2022","journal-title":"Nature Medicine"},{"issue":"8","key":"10.1016\/j.archger.2026.106443_bib0030","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1002\/ejhf.1498","article-title":"Initiation of sacubitril\/valsartan in haemodynamically stabilised heart failure patients in hospital or early after discharge: Primary results of the randomised TRANSITION study","volume":"21","author":"Wachter","year":"2019","journal-title":"European Journal of Heart Failure"}],"container-title":["Archives of Gerontology and Geriatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167494326003122?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167494326003122?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T20:40:43Z","timestamp":1791492043000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167494326003122"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2027,1]]},"references-count":44,"alternative-id":["S0167494326003122"],"URL":"https:\/\/doi.org\/10.1016\/j.archger.2026.106443","relation":{},"ISSN":["0167-4943"],"issn-type":[{"value":"0167-4943","type":"print"}],"subject":[],"published":{"date-parts":[[2027,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Insights from the therapy of heart failure at discharge (TESCODI) study: how far from full appropriateness are we in older and frail patients?","name":"articletitle","label":"Article Title"},{"value":"Archives of Gerontology and Geriatrics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.archger.2026.106443","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"106443"}}